Hemas Holdings Ltd. · CSELK:HHL.N0000
Hemas — Q1 FY24/25 Earnings Presentation
28 slides from Hemas's earnings presentation, 2024
Slide 1: Hemas Holdings PLC Investor Presentation Q1 FY24/25
Hemas Holdings PLC Investor Presentation- Q1 FY24/25
Slide 2: Who we are
Who we are Established in 1948, with a purpose of empowering families to live a better tomorrow, Hemas Holdings is one of Sri Lanka’s leading conglomerates listed in the Colombo Stock Exchange with focused interest in Consumer and Healthcare. USD 1948 2003 2007 2013 2018 2022 75 162mn Years in Marke
Slide 3: Implications of key macro economic parameters on Hemas
Implications of key macro economic parameters on Hemas Interest Rates Stable Exchange Rates Global Commodity prices “ Mixed impact of reduced prices “A gradual decline in AWPLR was “Positive impact from reduced RM of key commodities which witnessed during the year easing costs and import expenditure
Slide 4: Corporate Governance
Corporate Governance BOM Group CEO Nomination & Governance BOM (Board of Management) Consists of the senior leadership team of 11 members - Heads of our 6 businesses and 5 leaders from Corporate Committee Office. BOM is responsible for formulation and implementation of Group strategic plan and ensur
Slide 5: Long range plan: Key strategic pillars
Long range plan : Key strategic pillars Refreshing High A Enhancing the growth successful efficiencies portfolio spaces turnaround Consumer Brands Pursuing scalable Morison will pivot to Enhance efficiency aims to expand its opportunities across branded and market position presence in the South Asia
Slide 6: Long range plan: Key focus areas
Long range plan : Key focus areas ❖ Invest in complementary Hair and ❖ Shift focus to growing the ❖ Continue to strengthen a lean Beauty care, focus on local Morison brand in cardiac, diabetes, business model consumer needs, and drive and complementary medication, household penetration in while enha
Slide 7: New Product Launches during the Quarter
New Product Launches during the Quarter Home and Personal Care Gold Wild Cologne Spray “The core portfolio Baby Cheramy maintained robust Liquid Soap performance, demonstrating its market strength, while new product launches gained positive momentum. This success Goya Soap Jasmine Goya Soap White hi
Slide 8: Financial Snapshot
Financial Snapshot EBIT by Segment (LKR million) 3,133 211 3M contribution to the Group 2,031 2,153 1,930 351 434 225 455 35% 63% 2% 816 1,092 1,147 1,843 242 704 217 24% Revenue 1,153 1,090 1,287 42% 67% 835 726 (202) (260) (308) (628) EBIT FY22 Q1 FY23 Q1 FY24 Q1 FY25 Q1 FY24 Q4 Consumer Healthcar
Slide 9: Sector Performance Summary – Q1 FY 2024-25
Sector Performance Summary – Q1 FY 2024-25 Revenue Walk EBIT Walk (LKR Mn) (LKR Mn) 29,121 -2,190 -1,508 6 -58 25,482 231 197 -331 2,153 -320 1,930 Q1 FY 24 Consumer Healthcare Other Mobility Q1 FY 25 Q1 FY 24 Healthcare Mobility Consumer Other Q1 FY 25
Slide 10: Continuing Operation EPS – Q1 FY 2024-25
Continuing Operation EPS – Q1 FY 2024-25 EPS Walk (LKR Per Share) 0.88 -0.04 -0.37 -0.72 1.83 0.25 -0.56 1.58 0.59 -0.53 1.83 1.58 Q1 FY 24 Net Finance NCI Operating Income Tax Q1 FY 25 Q1 FY 24 Healthcare Mobility Consumer Other Q1 FY 25 Cost Profit
Slide 11: Capital Employed – FY 2024-25
Capital Employed – FY 2024-25 Sector Efficiency Capital Employed, ROCE, and EBIT by Sector 60% Mobility Consumer LKR 455.3 Mn 50% LKR 815.8 Mn 47.7% 43.5% 40% Healthcare 30% Group ROCE :26.1% LKR 1,287.1 Mn 20% 21.3% ROCE (%) 10% 0% 0 5 10 15 20 25 30 35 40 -10% -10.7% Capital Employed (LKR Bn) -20%
Slide 12: Consumer Brands
Consumer Brands ❖ Home and Personal Care - Sri Lanka ❖ Home and Personal Care - International ❖ Learning Segment
Slide 13: Consumer Brands
Consumer Brands Contribution to Group Sector Performance – 3M FY 2024-25 35% Key Highlights Revenue % Revenue (LKR Mn) • Consumer purchasing patterns continued to favour value-for-money 3M FY25 38% offerings, reflecting the ongoing 3M FY24 15,433 -19.8% constraints on consumer purchasing 15,000 (YoY
Slide 14: Home and Personal Care – Sri Lanka
Home and Personal Care – Sri Lanka 8 Key categories with market Purpose-driven brands touching the lives of the Sri Lankan consumer leading positions Extensions to the Portfolio Inclusive Strong roots Parenting Stronger Make a Celebrating Enabling Both parents together Positive Difference & Nurturin
Slide 15: Home and Personal Care – International
Home and Personal Care – International Locally led and localised in Bangladesh Reach in Bangladesh 2 Geographies Bangladesh & West Bengal • All products are exclusively designed for Bangladesh. Rural penetration by • Extensive product portfolio with multiple value 19.3% Hemas Key categories 3• Value
Slide 16: Home and Personal Care – Sri Lanka and International
Home and Personal Care – Sri Lanka and International Sri Lanka International Revenue Revenue Revenue (LKR Mn) • In line with market dynamics, price revisions • Despite the challenging market conditions, and promotions were implemented across -14.2% ‘Kumarika’ increased its market share in the VAHO t
Slide 17: Learning Segment
Learning Segment Revenue • ‘Atlas’ maintained its market leadership in 6 the mass market segment while also Key categories expanding its market share in both the Revenue (LKR Mn) premium and value-for-money segments • Reinforcing the brand’s commitment of ‘making learning fun’, several efforts were
Slide 18: Healthcare Sector
Healthcare Sector ❖ Pharmaceutical Import, Marketing and Distribution ❖ Pharmaceutical Manufacturing ❖ Hospitals
Slide 19: Healthcare
Healthcare Contribution to Group Sector Performance – 3M FY 2024-25 63% Revenue % Revenue (LKR Mn) Key Highlights 3M FY25 -8.6% 3M FY24 (YoY) 61% 17,639 17,912 18,237 18,000 16,130 • The Pharmaceutical industry continued 15,326 16,000 to contract into the first quarter, 14,000 although the rate of d
Slide 20: Pharmaceutical Import, Marketing, Distribution and Manufacturing
Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Revenue • Amidst market contraction and regulatory price reductions, the Pharmaceutical Distribution Business sustained its market leading position for the quarter. Revenue (LKR Mn) • The Distribution business expanded i
Slide 21: Hospitals
Hospitals Revenue • With fewer communicable diseases were reported compared to the same period last year, Revenue (LKR Mn) hospital admissions have experienced a slight 190+ Beds decline. 2,500 10.2 % • In contrast, there has been an increase in both (YoY) inpatient and outpatient volumes due to an
Slide 22: Mobility Sector
Mobility Sector ❖Maritime ❖Aviation
Slide 23: Mobility
Mobility Contribution to Group Sector Performance – 3M FY 2024-25 2% Revenue % Revenue (LKR Mn) Key Highlights 14.0% 3M FY25 1% (YoY) 3M FY24 500 460 458 476 418 • Amidst global challenges in the 376 400 maritime sector, intensified by tensions 300 in the Red Sea and anticipated tariff hikes on Chin
Slide 24: Environmental Agenda 2030
Environmental Agenda 2030 ENCOURAGING RESPONSIBLE PROTECTING SRI LANKAN ENDEMISM PLASTIC CONSUMPTION Protection of 10 critically endangered 720,000+ KG endemic species. The Group is committed to protect 52 by 2030 To Date Plastic Collection
Slide 25: Social Impact: 56,800+ Families Empowered
Social Impact: 56,800+ Families Empowered TACKLING PERIOD POVERTY PROVIDING WIGS TO CANCER PATIENTS CREATING A SAFER WORLD CREATING EQUAL LEARNING OPPURTUNITY 2,412 350 5,724 30,166 Women and Girls Women Families Children, Teachers and Parents CREATING QUALITY LEARNING EMPOWERING WOMEN AND PROVIDING
Slide 26: Sustainability Performance – Q1 2024-25 vs Q1 2023-24
Sustainability Performance – Q1 2024 – 25 vs Q1 2023 - 24 Values of Fines for Non-Compliance Carbon Footprint (per Rs. Mn Revenue) 7.7% 0.14MT with Laws and Regulations in the NONE Social Economic Area Water Consumption Total Work-Related Injury Rate (per Rs. Mn Revenue) 0% 1.6 m3 (per 100 employee)
Slide 27: Key Priorities
Key Priorities Focus on Personal care, Beauty and wellness with a drive for premiumisation and exploring underpenetrated Markets Corporate Priorities Strengthening value prepositions to grow market share Accelerating the M&A opportunities Accelerate exports and international expansion Consumer throu
Slide 28: Disclaimer
Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this